Tecentriq 840 MG/14 ML vial 14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM3HW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,345
Award facts
- Contract value 100% obligated
- $9,344.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,344.66 to AmerisourceBergen Drug Corp for the supply of Tecentriq 840 mg/14 ml vials on January 28, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by February 19, 2026, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. This contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at up to $999.99 million through December 31, 2031.
AmerisourceBergen serves as a critical pharmaceutical distributor supporting federal medical procurement needs across the Department of Defense and other government healthcare systems. The parent IDC with Cencora enables the supply of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs globally. This specific delivery order for Tecentriq, an oncology medication, exemplifies the company's role in fulfilling essential pharmaceutical requirements for federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FM3HW?
SPE2DR26FM3HW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FM3HW worth?
The government has obligated $9,345 on SPE2DR26FM3HW.
Is contract SPE2DR26FM3HW an order under another contract?
Yes. SPE2DR26FM3HW is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3HW competed?
The extent of competition for SPE2DR26FM3HW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award